BIORESTORATIVE THERAPIES, INC.: 10-Q filed 2017-08-14
What BIORESTORATIVE THERAPIES, INC. reported in its quarterly report filed 2017-08-14 (fiscal Q2 2017): 27 published measures, 69 facts as tagged in accession 0001493152-17-009275.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-08-14
- Fiscal period
- fiscal Q2 2017
- Accession
- 0001493152-17-009275 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIORESTORATIVE THERAPIES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 1,423,680 | USD | |
| At 2016-12-31 | 1,580,015 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 7,138,724 | USD | |
| At 2016-12-31 | 6,580,297 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -5,715,044 | USD | |
| At 2016-12-31 | -5,000,282 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -2,747,183 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -5,532,937 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -2,258,415 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -4,745,743 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 151,200 | USD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 20,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 27,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 16,155 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 25,280 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -47,492,735 | USD | |
| At 2016-12-31 | -41,959,798 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 416,556 | USD | |
| At 2016-12-31 | 508,594 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 2,283,111 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 1,355,327 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -2,569,015 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -5,058,386 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -2,143,146 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -4,210,280 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 46,551 | USD | |
| At 2016-12-31 | 73,400 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 6,994,188 | USD | |
| At 2016-12-31 | 5,844,860 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 2,466,839 | USD | |
| At 2016-12-31 | 2,283,981 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 20,000 | USD | |
| At 2016-12-31 | 6,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 2,589,015 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 5,085,386 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 2,159,230 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 4,235,479 | USD | 182 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 20,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 27,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 16,084 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 25,199 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 610,725 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 1,416,578 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 608,688 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 1,474,732 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 5,491,605 | shares | |
| At 2016-12-31 | 4,699,035 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 41,772,200 | USD | |
| At 2016-12-31 | 36,954,817 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 926,397 | USD | |
| At 2016-12-31 | 963,845 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 1,895,907 | USD | |
| At 2016-12-31 | 1,574,659 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 24,660 | USD | |
| At 2016-12-31 | 35,578 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 1,093,928 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 2,291,241 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 982,358 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 1,885,239 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 129,486 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 127,182 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -178,168 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -474,551 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -115,269 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -535,463 | USD | 182 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 14,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | -77,375 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 215,555 | USD | 181 |
| 2016-01-01 to 2016-06-30 | -377,197 | USD | 182 |
Inspect the source
- Entity
- BIORESTORATIVE THERAPIES, INC. / CIK 0001505497
- Captured
- 2026-09-19T11:18:28.483Z
- SEC response SHA-256
fd60c78bee3335eafd56c883fed2689ce9a2b29ba609bffc874788f5f89f9708
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001505497.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))